Skip to content
★ Sign in to follow
바이

바이오니아 Stock: price and insider trades · South Korea

KR·Mcap ₩175.8BHealth Care

No insider purchase over the last 90 days. The latest, by 이찬효, was filed 08 Jan 2026.

Insider Decl.
62
Thresholds
n/a
Buy Volume
€157,400
20 ops. · all time
Sell Volume
€462,971
1 ops. · all time

Who traded when

BuySale
박한오1 buy1 sale
기혜나1 buy
김성태1 buy
오종억1 buy
이삼용1 buy
이상규1 buy

+4 other insiders

Fundamental score
Ranked 16,946 of 26,897 companies
43.3
score / 100
Value
41
Quality
46
FCF yld1.9%
Earn yld-1.7%
EV/EBITDA11.5x
ROE·
Gross mgn78%
Net mgn-0.9%
Debt/EBITDA4.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩6,810
Analyst consensus
·
Income statement
Revenue₩330.1B
Gross profit₩257.2B78% margin
EBITDA₩23.5B7% margin
Net income-₩2.8B-0.9% margin
Balance sheet & cash
Market cap₩175.8B
Total debt₩106.4B
Free Cash Flow₩3.2B
Last declaration on 4 March 2026
Declarations64 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives
    0DART
  • ▼
    대표이사Executives(filed)
    €463kest.0DART
    60,240 sharesShareKRXDART:20260204000396
  • ▲
    Executives
    €743est.0DART
    100 sharesKRXDART:20260108000578
    Canonical exit: 31 Mar 2026 (T+90)
  • ▲
    이사Executives(filed)
    €1,738est.0DART
    234 sharesShareKRXDART:20260108000508
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    전무이사Executives(filed)
    €743est.0DART
    100 sharesShareKRXDART:20260108000542
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    이사Executives(filed)
    €5,208est.0DART
    701 sharesShareKRXDART:20260108000531
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    상무Executives(filed)
    €9,546est.0DART
    1,285 sharesShareKRXDART:20260108000485
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    이사Executives(filed)
    €2,466est.0DART
    332 sharesShareKRXDART:20260108000468
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    이사Executives(filed)
    €3,469est.0DART
    467 sharesShareKRXDART:20260108000448
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    이사Executives(filed)
    €3,469est.0DART
    467 sharesShareKRXDART:20260108000522
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    상무Executives(filed)
    €4,405est.0DART
    593 sharesShareKRXDART:20260108000475
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    이사Executives(filed)
    €624est.0DART
    84 sharesShareKRXDART:20260108000459
    Canonical exit: 8 Apr 2026 (T+90)
  • ▲
    이사Executives
    0DART
    ShareKRXDART:20240724000438
    Canonical exit: 17 Oct 2024 (T+90)
  • ▲
    전무이사Executives
    0DART
    ShareKRXDART:20240520000191
    Canonical exit: 11 Aug 2024 (T+90)
  • ▲
    Executives
    €14kest.0DART
    530 sharesKRXDART:20230918000221
    Canonical exit: 10 Dec 2023 (T+90)
  • ▲
    Executives
    €17kest.0DART
    530 sharesKRXDART:20230721000583
    Canonical exit: 15 Oct 2023 (T+90)
  • ●
    전무이사Executives
    0DART
    ShareKRXDART:20230519000580
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives(filed)
    €9,777est.0DART
    530 sharesKRXDART:20221021000367
    Canonical exit: 19 Jan 2023 (T+90)
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20221012000277
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20220920000199
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20220914000020

25 of 64 declarations

About 바이오니아

바이오니아, a South Korean health care company listed on the Korea Exchange market, has 62 filings between February 23, 2021 and March 4, 2026, of which 20 purchases, a single sale and 41 filings of another kind. Purchases make up 95% of open-market trades.

The most notable episode is clustered: between December 31, 2025 and January 8, 2026, 10 insiders filed purchases, which accounts for the 13 filings of 2026 and the last twelve months, with 10 purchases and one sale. Before that, activity had receded, from 28 filings in 2021 to 15 in 2022, 4 in 2023 and 2 in 2024.

Read moreShow less

Among the 11 filers, 이중열, filed with the function 전무이사, is the top one, with 35 filings, 2 of them purchases. 박한오, 대표이사, has 11, of which 9 purchases and one sale. The company itself, 바이오니아, appears with 7 filings, neither purchases nor sales, and 이삼용 and 한은수, both 이사, bought. Market capitalisation is KRW 201.3 billion, and filings appear a median of 7 days after the trade.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations